A. García

617 citations
22 papers · 339 indexed · h-index 10
Topics
Pancreatic and Hepatic Oncology Research (7 papers)Glioma Diagnosis and Treatment (4 papers)Lung Cancer Treatments and Mutations (4 papers)
Partner nations
SpainUnited StatesFrance

In The Last Decade

A. García

20 papers receiving 331 citations

Peers

A. García
Comparison fields: 5 of 48
  • Oncology 183
  • Pulmonary and Respiratory Medicine 180
  • Molecular Biology 84
  • Genetics 76
  • Cancer Research 56
Replace F. Mefti with:
F. Mefti France
Delano M. Pfeifle United States
James E. Krook United States
P Vennin France
O. Saunders United Kingdom
Ettie Piura Israel
Rania Chehade Canada
Renata Lottici Italy
Susan Percy Ivy United States
Karen Giselle Chee United States
A. García relative to F. Mefti France F. Mefti's profile →
Citations per field
00.5×3.2×
F. Mefti · 1×
Citations per year

Countries citing papers authored by A. García

Since Specialization
Citations

This map shows the geographic impact of A. García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. García more than expected).

Fields of papers citing papers by A. García

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. García. The network helps show where A. García may publish in the future.

Co-authorship network of co-authors of A. García

This figure shows the co-authorship network connecting the top 25 collaborators of A. García. A scholar is included among the top collaborators of A. García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. García. A. García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 1
5 11
6 10
7 7
8 6
9 28
10 1
11 16
12 32
13 8
14 13
15 22
16 33
17 1
18 0
19 125
20 1

About A. García

A. García is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 339 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Glioma Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Genetics (76 citations), Oncology (183 citations) and Pulmonary and Respiratory Medicine (180 citations). A. García has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Luis Paz‐Ares, Rafael Rosell, Ana Fernández Montés, Bartomeu Massutí, Guillermo López-Vivanco, Mariano Provencio, María L. Amador, J. M. Sanchez, H. Cortés-Funes and Claudio Ballestı́n. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026